SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Magellan Health, Inc. (NASDAQ: MGLN) announced today that Swati Abbott and Matthew J. Simas have been elected at the 2018 annual meeting of shareholders to Magellan’s board of directors. Both Abbott and Simas were nominated for election to the board to fill the seats previously held by Kay Coles James, president of the Heritage Foundation, and Mary Sammons, former chairperson and CEO of Rite Aid Corporation.
“We are fortunate to have two experienced healthcare industry leaders join our board of directors,” said Barry M. Smith, chairman and chief executive officer of Magellan Health. “As we continue to focus on leading humanity to healthy, vibrant lives, Matthew and Swati’s combined knowledge and skills will benefit our work to bring innovative solutions to the fastest growing, most complex areas of healthcare."
Since 2011, Abbott has served as the president and chief executive officer of Health Intelligence Company, LLC, doing business as Blue Health Intelligence, a healthcare data and analytics company. She has significant knowledge and experience in healthcare data analytics and managed care. Prior to joining Blue Health Intelligence, she was the president of MEDai, Inc., an industry leader in predictive analytics which was acquired by Reed Elsevier in 2008. She also served as managing director for the Medical Management Strategic Business Unit at ViPS. Abbott currently serves as a director of Prognos, Inc., a private healthcare data analytics company, and The Family Institute, a non-profit agency involved in clinical service, education and research.
Simas currently serves as the director of Truveris, Inc., a private healthcare services company providing transparency to the prescription drug ecosystem through data-driven innovations. He has 30 years of experience in the healthcare industry with extensive expertise in health technology and in the pharmacy benefits management (PBM) industry. Simas was founder, chairman and chief executive officer of MedInitiatives, Inc., a provider of business intelligence technology and data analytics serving the pharmacy benefit manager, payer and pharma markets, which was acquired by IMS Health in 2007. He also held previous roles as a director of MedImpact Healthcare Systems, Inc., and the executive chairman of BusinessOne Technologies, Inc. Simas also served as the chairman and interim chief executive officer of Alliance Health (now UpWell), a private healthcare company providing services to members with chronic health conditions.
“We thank Kay and Mary for their valuable contributions over the years and we greatly appreciate their guidance and leadership as members of our board,” said Smith.
About Magellan Health: Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.